[Translation] A multicenter, open, randomized, controlled, phase III clinical study comparing the pharmacokinetic characteristics, efficacy, and safety of toripalimab injection (for subcutaneous injection) (JS001sc) and toripalimab injection (JS001) combined with standard chemotherapy as first-line treatment for recurrent or metastatic non-squamous non-small cell lung cancer
在复发或转移性非鳞非小细胞肺癌(NSCLC)患者中评估JS001sc对比JS001的药代动力学、安全性及疗效
[Translation] To evaluate the pharmacokinetics, safety, and efficacy of JS001sc versus JS001 in patients with recurrent or metastatic non-squamous non-small cell lung cancer (NSCLC)